Compare Nuwellis Inc (NUWE) vs Oatly Group AB - ADR (OTLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Oatly Group AB - ADR — how do they compare? Nuwellis Inc trades at $0.8 (market cap $2.54M), while Oatly Group AB - ADR trades at $12.53 (market cap $402.73M). The key difference: Oatly Group AB - ADR is far larger — about 158.6× Nuwellis Inc's market cap, and Oatly Group AB - ADR is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| NUWE | OTLY | |
|---|---|---|
Market Cap | $2.54M | $402.73M |
Sector | Technology | Consumer Staples |
52-Week High | $164.50 | $18.09 |
52-Week Low | $0.73 | $8.03 |
Enterprise Value | -$1.17M | $907.14M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.7878, up 0.88% today, but remains in a bearish technical trend. The company shows strong gross margins of 69.69% and double-digit revenue growth, but faces significant profitability challenges with negative net income margins and ROE. Recent developments include a reverse stock split, new CEO appointment, and strategic partnerships expanding pediatric care footprint.
While NUWE demonstrates operational progress with revenue growth and margin improvement, persistent losses and negative cash flow present substantial risk. The mixed analyst sentiment and bearish technical indicators suggest cautious approach. Investment appeal hinges on successful execution of financial efficiency strategy and path to profitability.
Oatly (OTLY) trades at $13.52, down 3.98% today, with a bullish technical signal from a recent golden cross but bearish moving averages. Revenue growth improved to $862.46M in 2025, yet net losses persist at -$152.77M. The company raised its 2026 revenue outlook after Q2 results, driving positive sentiment from news outlets like Seeking Alpha on July 22, 2026.
Outlook hinges on margin expansion and path to profitability, with risks from high debt and cash burn. Analysts are mixed (44% buy, 50% hold), reflecting optimism on operational turnaround but caution on financial sustainability. Key catalysts include product innovation and market expansion, though negative cash flows and equity erosion pose significant investor risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Oatly Group AB - ADR
Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, Icecreams, among others. It caters to Sweden, Germany, United Kingdom, Netherlands, North America, Finland, and other markets.
Read more on OTLY →
